Cure First's mission is to accelerate the discovery of targeted, safer and more effective treatments for cancer. By combining breakthroughs in functional genomics, high throughput screening and bioinformatics, we rapidly pinpoint the unique vulnerabilities of different cancer cells. Ultimately, this will allow us to analyze individual tumors, one by one, and to select the most specific and effective treatments for each patient. This targeted approach to cancer therapy promises to be less toxic, more effective, and more individualized than any we have seen before.
Each of GlobalGiving’s nonprofit partners is required to send quarterly donor reports detailing the impact of their work.